Fundraising FoxMiracor Medical
9 known investors
Find your way into Miracor Medical
Sign up to see every warm intro you have to Miracor Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Miracor Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients. The company focuses on cardiac disease medical technology aimed at improving outcomes and preventing heart failure.
Investors · 9
How we know: Delta Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Ming capital's portfolio page · Not right? Tell us
How we know: nordic9.com · Not right? Tell us
How we know: funding news · nordic9.com · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: nordic9.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ESep 2020
Earlybird, Noshaq, Quest for Growth, SFPI-FPIM, SRIW, Yonghua
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- MIRACOR MEDICAL UK LIMITED
- Company number
- 13351395
- Status
- Dissolved
- Company type
- Private limited company
- Incorporated
- 22 Apr 2021
- Dissolved
- 24 Dec 2024
- Registered office
- Fairbourne Drive, Atterbury, Milton Keynes, Buckinghamshire, MK10 9RG
- Nature of business (SIC)
- 26600 — Manufacture of irradiation, electromedical and electrotherapeutic equipment
- Accounts
- last made up to 30 Apr 2023
- Confirmation statement
- last made up to 21 Apr 2024
Current officers
- Olivier Delporte — director, appointed 22 Apr 2021
- Gillian Margaret Glennon — director, appointed 17 May 2021
- Bertrand Grimmonpre — director, appointed 22 Apr 2021
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Miracor Medical do?
- Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients. The company focuses on cardiac disease medical technology aimed at improving outcomes and preventing heart failure.
- Who are Miracor Medical's investors?
- Miracor Medical's investors include Delta Partners, Ming capital, Bek Ventures, Quest for Growth, SHS Capital, Yonghua Capital.